Business

Novo Nordisk Expands Wegovy Pill to UAE

Updated 2026-06-03 08:05 UTC 1 source Neutral

Novo Nordisk has launched its weight loss drug Wegovy in the United Arab Emirates as its first market outside the U.S., guided by patient demand and healthcare infrastructure.

Coverage timeline — 2 articles
CNBC
Novo's approach to global launches will be guided by patient demand and the strength of healthcare and telehealth infrastructure, the drugmaker said.
2026-06-03 07:42 UTC
CNBC
Goldman Sachs is acting as a joint book-running manager for Alphabet's underwritten offerings.
2026-06-03 07:56 UTC
Share: Twitter / X LinkedIn